新加坡实验室培育海鲜的商业化困境
In the gleaming laboratories of Singapore’s Jurong Innovation District, a handful of start-ups are quietly rewriting the future of marine protein. Unlike plant-based alternatives that have already colonised supermarket shelves, cultivated seafood — grown from fish cells in bioreactors rather than hauled from the ocean — remains a technological enigma with a stubbornly high price tag. The city-state, which became the first regulator to approve cell-cultured meat for commercial sale in 2020, has since positioned itself as a global test bed for this nascent industry. Yet beneath the buzz of pilot plants and government grants, a sobering reality has taken hold: scaling production from petri dish to profitability demands not only scientific breakthroughs but also a fundamental rethinking of supply chains and consumer psychology.
The technical hurdles are formidable. Cultivating fish muscle tissue at scale requires precisely controlled environments, expensive growth media — often derived from foetal bovine serum, an ethically fraught component — and continuous energy inputs that erode margins. Whereas plant-based meats rely on extrusion processes refined over decades, cellular agriculture remains in its industrial infancy. Start-ups have pivoted from whole fillets to minced products such as crab cakes or shrimp dumplings, conceding that texture replication for structured cuts is years away. Industry observers note that even the most advanced firms, operating pilot lines producing a few tonnes annually, are still orders of magnitude removed from the thousands of tonnes needed to justify capital expenditures projected in the hundreds of millions of dollars.
Vocabsavvy AI · a business reporter tracking global consumer trends, startups, work, money and the new-energy economy across markets worldwide · Vocabsavvy Original